The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype.

The aim of this study was to investigate the possible role of STAT4 gene in the genetic predisposition to systemic sclerosis (SSc) susceptibility or clinical phenotype. A total of 1317 SSc patients [896 with limited cutaneous SSc (lcSSc) and 421 with diffuse cutaneous SSc (dcSSc)] and 3113 healthy controls, from an initial case-control set of Spanish Caucasian ancestry and five independent cohorts of European ancestry (The Netherlands, Germany, Sweden, Italy and USA), were included in the study. The rs7574865 polymorphism was selected as STAT4 genetic marker. We observed that the rs7574865 T allele was significantly associated with susceptibility to lcSSc in the Spanish population [P = 1.9 x 10(-5) odds ratio (OR) 1.61 95% confidence intervals (CI) 1.29-1.99], but not with dcSSc (P = 0.41 OR 0.84 95% CI 0.59-1.21). Additionally, a dosage effect was observed showing individuals with rs7574865 TT genotype higher risk for lcSSc (OR 3.34, P = 1.02 x 10(-7) 95% CI 2.11-5.31). The association of the rs7574865 T allele with lcSSc was confirmed in all the replication cohorts with different effect sizes (OR ranging between 1.15 and 1.86), as well as the lack of association of STAT4 with dcSSc. A meta-analysis to test the overall effect of the rs7574865 polymorphism showed a strong risk effect of the T allele for lcSSc susceptibility (pooled OR 1.54 95% CI 1.36-1.74; P < 0.0001). Our data show a strong and reproducible association of the STAT4 gene with the genetic predisposition to lcSSc suggesting that this gene seems to be one of the genetic markers influencing SSc phenotype.

[1]  M. Gershwin,et al.  The immunobiology of systemic sclerosis. , 2008, Seminars in arthritis and rheumatism.

[2]  M. Zervou,et al.  STAT4: a risk factor for type 1 diabetes? , 2008, Human immunology.

[3]  E. G. de la Concha,et al.  Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases. , 2008, Arthritis and rheumatism.

[4]  John P A Ioannidis,et al.  Effect of formal statistical significance on the credibility of observational associations. , 2008, American journal of epidemiology.

[5]  C. Wijmenga,et al.  Association of STAT4 with rheumatoid arthritis: a replication study in three European populations. , 2008, Arthritis and rheumatism.

[6]  J. Reveille,et al.  The contribution of genes outside the major histocompatibility complex to susceptibility to ankylosing spondylitis , 2008, Current opinion in rheumatology.

[7]  A. Syvänen,et al.  A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5 , 2008, Human molecular genetics.

[8]  Judy H. Cho,et al.  The genetics and immunopathogenesis of inflammatory bowel disease , 2008, Nature Reviews Immunology.

[9]  J. Anaya,et al.  STAT4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians , 2008, Genes and Immunity.

[10]  F. Holsboer,et al.  IL 2 RA and IL 7 RA genes confer susceptibility for multiple sclerosis in two independent European populations , 2008 .

[11]  F. Arnett,et al.  Genetics and genomic studies in scleroderma (systemic sclerosis). , 2008, Rheumatic diseases clinics of North America.

[12]  M. Fujimoto,et al.  Increased serum interleukin 23 in patients with systemic sclerosis. , 2008, The Journal of rheumatology.

[13]  John P. A. Ioannidis,et al.  Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls , 2008, Human Genetics.

[14]  D. Abraham,et al.  Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma , 2007, Nature Clinical Practice Rheumatology.

[15]  Wentian Li,et al.  STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. , 2007, The New England journal of medicine.

[16]  Z. Nagy,et al.  Regulation of T cell homeostasis by JAKs and STATs , 2007, Archivum Immunologiae et Therapiae Experimentalis.

[17]  D. G. Zisoulis,et al.  Stat3 and Stat4 Direct Development of IL-17-Secreting Th Cells1 , 2007, The Journal of Immunology.

[18]  P. Gregersen,et al.  Genetics of autoimmune diseases — disorders of immune homeostasis , 2006, Nature Reviews Genetics.

[19]  Xinmin Cao,et al.  Structure, function, and regulation of STAT proteins. , 2006, Molecular bioSystems.

[20]  P. Gregersen,et al.  PTPN22: setting thresholds for autoimmunity. , 2006, Seminars in immunology.

[21]  D. Abraham,et al.  Mechanisms and consequences of fibrosis in systemic sclerosis , 2006, Nature Clinical Practice Rheumatology.

[22]  T. Merriman,et al.  Genetic progress towards the molecular basis of common autoimmunity. , 2006, Discovery medicine.

[23]  Yuka Kanno,et al.  Signaling by IL‐12 and IL‐23 and the immunoregulatory roles of STAT4 , 2004, Immunological reviews.

[24]  U. Zettl,et al.  Transcription factors in autoimmune diseases. , 2004, Current pharmaceutical design.

[25]  S. Jimenez,et al.  Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis , 2004, Annals of Internal Medicine.

[26]  C. Denton,et al.  Assessment of lung involvement. , 2003, Clinical and experimental rheumatology.

[27]  T. Medsger,et al.  Criteria for the classification of early systemic sclerosis. , 2001, The Journal of rheumatology.

[28]  M. Hasegawa,et al.  Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis. , 2000, The Journal of rheumatology.

[29]  S. Baigent,et al.  Elevated levels of corticotrophin-releasing factor binding protein in the blood of patients suffering from arthritis and septicaemia and the presence of novel ligands in synovial fluid. , 1996, British journal of rheumatology.

[30]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[31]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.